AUG 3, 2026 · PHASE 2 TRIAL
Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab Injection in sqNSCLC Participants.
ClinicalTrials.gov
This is a Phase 2 trial registration with no posted results; the study is not yet recruiting and planned enrollment is modest, making it too early to assess efficacy or safety.
Reported
Planned enrollment156
Study phasePhase 2
Primary outcome measureTEAEs (treatment-emergent adverse events),…